المؤلفون: V. A. Papadmitrakopoulou, J. T. Beck, Neil Miller, S. Urva, Bruce E. Johnson, Ilona Pylvaenaeinen, Benjamin Besse, C. Mulatero, Peter Schmid, Katarina Petrovic, Sasa Dimitrijevic, Rebecca S. Heist, D.R. Camidge

المصدر: Annals of Oncology. 25:505-511

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Lung Neoplasms, Maximum Tolerated Dose, Neutropenia, Disease-Free Survival, Drug Administration Schedule, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Everolimus, Adverse effect, Lung cancer, Etoposide, Aged, Neoplasm Staging, Sirolimus, business.industry, Hematology, Middle Aged, medicine.disease, Small Cell Lung Carcinoma, Granulocyte colony-stimulating factor, Treatment Outcome, Cohort, Female, Cisplatin, business, Febrile neutropenia, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6d077685ba26305f5530aef82cb9ad
https://doi.org/10.1093/annonc/mdt535